DNA vaccines for the prevention and treatment of allergy
10.1097/ACI.0b013e3283207ad8
Saved in:
Main Authors: | Chua, K.Y., Kuo, L.-C., Huang, C.-H. |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Review |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/25734 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
by: Russell, F.M., et al.
Published: (2014) -
DNA vaccines and allergic diseases
by: Chua, K.Y., et al.
Published: (2011) -
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX™ in healthy children
by: Lau, Y.-L., et al.
Published: (2013) -
Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials
by: Whitworth, Hilary S, et al.
Published: (2021) -
Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy children
by: Tan, A.Y.S., et al.
Published: (2013)